CNS Pharmaceuticals Inc

CNSP

Company Profile

  • Business description

    CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

  • Contact

    2100 West Loop South
    Suite 900
    HoustonTX77027
    USA

    T: +1 800 946-9185

    https://www.cnspharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2024

    Employees

    3

Stocks News & Analysis

stocks

The surge in price of ASX listed share price is unwarranted

Good news as a proposed merger is approved but investors may be too optimistic. 
stocks

11 ASX dividend stocks for the next decade

What are the best stocks to own that can pay regular dividends and beat indices on a total return basis in the long-term? Here is our list of 11 ASX-listed companies that could help investors achieve these goals.
stocks

10 defensive ASX stocks to own in an expensive market

These shares may protect an investor in a volatile market. 

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,552.6071.000.84%
CAC 407,338.6786.93-1.17%
DAX 4019,215.48147.04-0.76%
Dow JONES (US)43,988.99259.650.59%
FTSE 1008,072.3968.35-0.84%
HKSE20,728.19225.15-1.07%
NASDAQ19,286.7817.320.09%
Nikkei 22539,500.37118.960.30%
NZX 50 Index12,770.33188.951.50%
S&P 5005,995.5422.440.38%
S&P/ASX 2008,295.1068.800.84%
SSE Composite Index3,452.3018.36-0.53%

Market Movers